The Department of Health and Social Care has committed £30 million to fight global AMR, delivered through 4 new projects as part of the Global AMR Innovation Fund (GAMRIF).
The European Commission have published proposals for how it will allocate its budget for science spending in the next EU budget. The funding programme - Horizon Europe - is the successor to Horizon 2020 and covers the period 2021-2027.
A new £56 million UK innovation centre, set to revolutionise how medicines are manufactured, is to be located in Renfrewshire, Scotland, allowing the UK to capture a bigger slice of the global £98 billion small molecule pharma market.
The Prime Minister Theresa May has announced that the NHS in England is to get an extra £20 billion a year by 2023.
ABPI’s Disclosure UK shows the pharmaceutical industry continues to invest in UK R&D:
“We are now fewer than nine months away from the day the UK leaves the EU and as it stands we still do not have a deal on the future relationship or any certainty on the conditions our companies are expected to operate under come 29 March 2019...
A survey into Brexit planning by pharmaceutical companies has been published by the European Medicines Agency (EMA).
Simon Stevens appeared on the Andrew Marr Show on Sunday 1 July and was asked about preparations for Brexit and contingency planning for a no-deal scenario to ensure the continued supply of medicines to the UK.
Today sees the launch of a consultation on proposals to change the 2016 ABPI Code of Practice for the pharmaceutical industry.
The ABPI today welcomes the publication of technical notices issued by the Government and the letter from the Department of Health and Social Care on medicines supply contingency planning. This gives guidance to pharmaceutical companies as they prepare for Brexit.